Oncology Institute Stock Forecast - Simple Regression

TOI Stock  USD 1.17  0.01  0.86%   
The Simple Regression forecasted value of Oncology Institute on the next trading day is expected to be 1.28 with a mean absolute deviation of  0.08  and the sum of the absolute errors of 4.97. Oncology Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Oncology Institute stock prices and determine the direction of Oncology Institute's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Oncology Institute's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Oncology Institute's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Oncology Institute's systematic risk associated with finding meaningful patterns of Oncology Institute fundamentals over time.
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
  
As of now, Oncology Institute's Inventory Turnover is decreasing as compared to previous years. The Oncology Institute's current Receivables Turnover is estimated to increase to 9.85, while Payables Turnover is projected to decrease to 12.26. . The Oncology Institute's current Net Income Applicable To Common Shares is estimated to increase to about 64.3 K, while Common Stock Shares Outstanding is projected to decrease to under 68.4 M.
Most investors in Oncology Institute cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Oncology Institute's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Oncology Institute's price structures and extracts relationships that further increase the generated results' accuracy.
Simple Regression model is a single variable regression model that attempts to put a straight line through Oncology Institute price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Oncology Institute Simple Regression Price Forecast For the 20th of April

Given 90 days horizon, the Simple Regression forecasted value of Oncology Institute on the next trading day is expected to be 1.28 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.97.
Please note that although there have been many attempts to predict Oncology Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oncology Institute's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Oncology Institute Stock Forecast Pattern

Backtest Oncology InstituteOncology Institute Price PredictionBuy or Sell Advice 

Oncology Institute Forecasted Value

In the context of forecasting Oncology Institute's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oncology Institute's downside and upside margins for the forecasting period are 0.01 and 6.36, respectively. We have considered Oncology Institute's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.17
1.28
Expected Value
6.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Oncology Institute stock data series using in forecasting. Note that when a statistical model is used to represent Oncology Institute stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.5724
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0814
MAPEMean absolute percentage error0.0504
SAESum of the absolute errors4.9653
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Oncology Institute historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Oncology Institute

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncology Institute. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oncology Institute's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.196.29
Details
Intrinsic
Valuation
LowRealHigh
0.081.546.64
Details
1 Analysts
Consensus
LowTargetHigh
2.282.502.78
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Oncology Institute. Your research has to be compared to or analyzed against Oncology Institute's peers to derive any actionable benefits. When done correctly, Oncology Institute's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Oncology Institute.

Other Forecasting Options for Oncology Institute

For every potential investor in Oncology, whether a beginner or expert, Oncology Institute's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncology. Basic forecasting techniques help filter out the noise by identifying Oncology Institute's price trends.

Oncology Institute Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Oncology Institute Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncology Institute's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncology Institute's current price.

Oncology Institute Market Strength Events

Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns.

Oncology Institute Risk Indicators

The analysis of Oncology Institute's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncology Institute in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncology Institute's short interest history, or implied volatility extrapolated from Oncology Institute options trading.

Currently Active Assets on Macroaxis

When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Oncology Stock analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Oncology Institute's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
4.397
Quarterly Revenue Growth
0.201
Return On Assets
(0.16)
Return On Equity
(0.92)
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.